ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity

Teva GTC · 2006
ClinicalTrials.gov · Datasets · License: Public Domain · 2006
Open Source ↗
multiple-sclerosis
muscle spasticity, multiple sclerosis, spasticity, sublingual tizanidine, ashworth scores, spasticity in multiple sclerosis patients, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 864731
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.